SOURCE: Esterline Technologies

October 10, 2007 07:00 ET

Esterline Technologies Corporation Agrees to Sell 3,450,000 Shares of Common Stock

BELLEVUE, WA--(Marketwire - October 10, 2007) - Esterline Technologies Corporation (NYSE: ESL) (www.esterline.com), a leading specialty manufacturer serving aerospace/defense markets, announced today that it has agreed to sell 3,450,000 shares of its common stock at an initial public offering price of $55.00 per share in an underwritten public offering. Net proceeds from the offering are expected to be used to repay outstanding debt under credit facilities and for general corporate purposes. The sale will be made under Esterline's effective shelf registration statement previously filed with the Securities and Exchange Commission. The sole underwriter for the offering is Jefferies & Company, Inc.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

A copy of the final prospectus supplement relating to the offering may be obtained, when available, from Jefferies & Company, Inc., Equity Capital Markets, 520 Madison Avenue, New York, NY 10022: 1-888-449-2342.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should" or "will," or the negative of such terms, or other comparable terminology. These forward-looking statements are based on the current intent and expectations of the management of Esterline, are not guarantees of future performance or actions, and involve risks and uncertainties that are difficult to predict. Esterline's actual results and the timing and outcome of events, including the offering and the use of proceeds from the offering, may differ materially from those expressed in or implied by the forward-looking statements due to risks and uncertainties such as those detailed in Esterline's public filings with the Securities and Exchange Commission, including the final prospectus supplement referenced above.

Contact Information

  • Contact:
    Brian Keogh
    425-453-9400